Showing 71 - 80 of 5,905
This paper analyzes the technology commercialization strategy of an innovating firm when the incumbent firms possess specialized commercialization capabilities. According to the predominant framework, if the innovation is protected by a strong appropriabilty regime the optimal strategy is to...
Persistent link: https://www.econbiz.de/10010357556
biotechnology and pharmaceutical firms. Fifteen control rights are identified to make up the structure of deals with five rights …
Persistent link: https://www.econbiz.de/10010383035
This paper addresses the evolution of biotechnology clusters in Germany between 1996 and 2003, paying particular … attention to their respective composition in terms of venture capital, basic science institutions and biotechnology firms …
Persistent link: https://www.econbiz.de/10010383036
Persistent link: https://www.econbiz.de/10010387313
Persistent link: https://www.econbiz.de/10010194276
Persistent link: https://www.econbiz.de/10010194279
Persistent link: https://www.econbiz.de/10010194281
Persistent link: https://www.econbiz.de/10010194295
Persistent link: https://www.econbiz.de/10010194298
Persistent link: https://www.econbiz.de/10010194302